Cefaly
20 articles about Cefaly
-
CEFALY Technology Selected to Present TEAM Study Findings at the Military Health System Research Symposium
8/9/2023
Medical device maker CEFALY Technology will present findings from the TEAM study at the Military Health System Research Symposium August 14-17, 2023, in Kissimmee, FL.
-
Now Over-the-Counter: FDA Clears CEFALY® DUAL Migraine Treatment for Use Without a Prescription
10/13/2020
CEFALY Technology today announced that the U.S. Food and Drug Administration (FDA) has cleared the CEFALY DUAL medical device as an over-the-counter (OTC) product
-
CEFALY Technology Partners with AZOVA Telemedicine Platform for Virtual Migraine Treatment Prescriptions
6/8/2020
The FDA-cleared preventive and abortive, prescribed, migraine treatment will now be available to migraine sufferers more quickly, without having to leave their homes to seek relief [08-June-2020] NEW YORK , June 8, 2020 /PRNewswire/ -- CEFALY , the first device of its kind to receive FDA medical clearance for migraine headaches, is now expanding access to its prescri
-
CEFALY Technology Launches Giveaway to Win a CEFALY DUAL Migraine Treatment Device
6/4/2020
Weekly prizes aim to reduce migraine days for patients and culminate in a grand prize of the FDA-cleared medical device to mark National Migraine and Headache Awareness Month this June [04-June-2020] NEW YORK , June 4, 2020 /PRNewswire/ -- CEFALY , the first device of its kind to receive FDA medical clearance for migraine headaches, is launching a nationwide giveaway
-
Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly
6/18/2018
The Cefaly® ACUTE medical device was recently cleared by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine
-
Chronic Migraine Prevention Trial Shows Positive Results for Cefaly® PREVENT Medical Device
5/31/2018
The Cefaly® PREVENT medical device was successful in a recent trial for chronic migraine prevention.
-
Migraine Abortion Trial Shows Positive Results for Cefaly Acute Medical Device
1/24/2018
The Cefaly Acute medical device, cleared by the FDA two months ago for the acute treatment of migraine with or without aura, was also successful in a recent trial for migraine abortion.
-
FDA-Approved Cefaly Device to Stop Migraines Now Available
11/29/2017
The new FDA-approval follows several clinical trials that demonstrated that one hour of e-TNS with the Cefaly ACUTE can relieve or stop the migraine headache.
-
Imaging Study Expands Upon Previous Findings That Cefaly Device Is Effective In Blocking Migraine Pain
7/25/2017
-
Migraine Medical Device Cefaly Introduces Option To Buy Now And Pay Later Through PayPal Credit
6/19/2017
-
Cefaly Release: Study Finds Migraine Device Cefaly An Effective Treatment For Refractory Migraine
6/12/2017
-
Cefaly Release: Migraine Medical Device Cefaly Is Successful In A Recent Trial On Chronic Migraine
6/7/2017
-
Migraine Medical Device Cefaly Releases Revamped Pocket-Sized Model Of FDA Approved Headband
7/18/2016
-
Migraine Medical Device Cefaly Shows Better Long-Term Patient Compliance Than Migraine Medication
2/15/2016
-
Cefaly Release: New Study Finds CEFALY Has Very High Efficacy For Migraine Prevention
8/26/2015
-
New Study Shows Cefaly Returns Normal Metabolic Activity To Brain Areas In Migraine Patients
6/1/2015
-
Cefaly To Present Breakthrough Data In Migraine Treatment At International Headache Society Congress
5/6/2015
-
10,000 U.S. Migraine Patients Who Used FDA-Approved Cefaly® Device Find Relief
1/20/2015
-
Migraine Prevention Device Cefaly Opens U.S. Office For Faster Delivery, Quicker Relief
12/8/2014
-
FDA Approves Cefaly's Device To Treat Migraine Headaches
3/12/2014